arrow
S

Samuel Fernandes

Universidade Federal de Minas Gerais
H指数:16
被引数:1,119

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal profiles of fecal calprotectin and C-reactive protein in relation to outcomes in Crohn's disease patients on infliximab

克罗恩病患者在英夫利昔单抗治疗期间,粪钙卫蛋白和C反应蛋白的纵向变化与治疗结局的关系

2025-08-011
PRE
Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched Analysis

早期自上而下的生物制剂治疗可提高克罗恩病黏膜下缓解率——一项风险调整后的倾向性评分匹配分析

2025-06-010
PRE
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study
2025-01-180
OAAI
Type 2 inflammation: a Portuguese consensus using Web-Delphi and decision conferencing (INFLAT2-PT)
2025-01-070
PRE
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study
2024-02-020
OAAI
Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study]
2024-01-193
PRE
The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients
2024-01-192
PRE
Transmural remission improves clinical outcomes up to 5 years in Crohn's disease
2022-12-2713
OAAI